
David J. Blanchard
Examiner (ID: 10564)
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1643, 1642, 1619 |
| Total Applications | 552 |
| Issued Applications | 169 |
| Pending Applications | 113 |
| Abandoned Applications | 273 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5826965
[patent_doc_number] => 20060062786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Antibodies that immunospecifically bind to TRAIL receptors'
[patent_app_type] => utility
[patent_app_number] => 11/221281
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 192046
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20060062786.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221281
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221281 | Antibodies that immunospecifically bind to TRAIL receptors | Sep 7, 2005 | Abandoned |
Array
(
[id] => 5742814
[patent_doc_number] => 20060088539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Modified antibodies to prostate-specific membrane antigen and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/219563
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 88733
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088539.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219563
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219563 | Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen | Sep 1, 2005 | Issued |
Array
(
[id] => 5827016
[patent_doc_number] => 20060062793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Modified antibodies to prostate-specific membrane antigen and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/218813
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 87985
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20060062793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11218813
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/218813 | Modified antibodies to prostate-specific membrane antigen and uses thereof | Sep 1, 2005 | Abandoned |
Array
(
[id] => 4999346
[patent_doc_number] => 20070041980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'CA6 antigen-specific cytotoxic conjugate and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 11/213046
[patent_app_country] => US
[patent_app_date] => 2005-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 27534
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20070041980.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213046
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213046 | CA6 antigen-specific cytotoxic conjugate and methods of using the same | Aug 28, 2005 | Issued |
Array
(
[id] => 5766776
[patent_doc_number] => 20060018900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Self antigen vaccines for treating B-cell lymphomas and other cancers'
[patent_app_type] => utility
[patent_app_number] => 11/209592
[patent_app_country] => US
[patent_app_date] => 2005-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 26893
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018900.pdf
[firstpage_image] =>[orig_patent_app_number] => 11209592
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/209592 | Self antigen vaccines for treating B-cell lymphomas and other cancers | Aug 21, 2005 | Abandoned |
Array
(
[id] => 330626
[patent_doc_number] => 07511122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-31
[patent_title] => 'Humanized and chimeric antibodies specific for lipoteichoic acid of GRAM positive bacteria'
[patent_app_type] => utility
[patent_app_number] => 11/193440
[patent_app_country] => US
[patent_app_date] => 2005-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16697
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/511/07511122.pdf
[firstpage_image] =>[orig_patent_app_number] => 11193440
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/193440 | Humanized and chimeric antibodies specific for lipoteichoic acid of GRAM positive bacteria | Jul 31, 2005 | Issued |
Array
(
[id] => 459382
[patent_doc_number] => 07237491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-03
[patent_title] => 'Variable function person transportation system(s)'
[patent_app_type] => utility
[patent_app_number] => 11/193404
[patent_app_country] => US
[patent_app_date] => 2005-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 39
[patent_no_of_words] => 11764
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/237/07237491.pdf
[firstpage_image] =>[orig_patent_app_number] => 11193404
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/193404 | Variable function person transportation system(s) | Jul 31, 2005 | Issued |
Array
(
[id] => 5819987
[patent_doc_number] => 20060024300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Immunoglobulin variants and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/190364
[patent_app_country] => US
[patent_app_date] => 2005-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 37303
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024300.pdf
[firstpage_image] =>[orig_patent_app_number] => 11190364
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/190364 | Immunoglobulin variants and uses thereof | Jul 25, 2005 | Abandoned |
Array
(
[id] => 5769162
[patent_doc_number] => 20060019923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Methods and compositions for inducing innate immune responses'
[patent_app_type] => utility
[patent_app_number] => 11/184065
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22383
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019923.pdf
[firstpage_image] =>[orig_patent_app_number] => 11184065
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/184065 | Methods and compositions for inducing innate immune responses | Jul 17, 2005 | Abandoned |
Array
(
[id] => 5769162
[patent_doc_number] => 20060019923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Methods and compositions for inducing innate immune responses'
[patent_app_type] => utility
[patent_app_number] => 11/184065
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22383
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019923.pdf
[firstpage_image] =>[orig_patent_app_number] => 11184065
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/184065 | Methods and compositions for inducing innate immune responses | Jul 17, 2005 | Abandoned |
Array
(
[id] => 318832
[patent_doc_number] => 07521542
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-21
[patent_title] => 'Humanized FcγRIIB-specific antibodies and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/126978
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 62737
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/521/07521542.pdf
[firstpage_image] =>[orig_patent_app_number] => 11126978
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/126978 | Humanized FcγRIIB-specific antibodies and methods of use thereof | May 9, 2005 | Issued |
Array
(
[id] => 5246962
[patent_doc_number] => 20070243196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Mage-3 and NY-ESO-1 Based Polyvalent Vaccine for Cancer Immunotherapy'
[patent_app_type] => utility
[patent_app_number] => 11/568566
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5079
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243196.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568566
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568566 | Mage-3 and NY-ESO-1 Based Polyvalent Vaccine for Cancer Immunotherapy | May 1, 2005 | Abandoned |
Array
(
[id] => 263909
[patent_doc_number] => 07569674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => 'Autophilic antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/119404
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12022
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569674.pdf
[firstpage_image] =>[orig_patent_app_number] => 11119404
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/119404 | Autophilic antibodies | Apr 28, 2005 | Issued |
Array
(
[id] => 7243643
[patent_doc_number] => 20050271670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Treatments for cancer'
[patent_app_type] => utility
[patent_app_number] => 11/119309
[patent_app_country] => US
[patent_app_date] => 2005-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9516
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0271/20050271670.pdf
[firstpage_image] =>[orig_patent_app_number] => 11119309
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/119309 | Treatments for cancer | Apr 27, 2005 | Abandoned |
Array
(
[id] => 5894883
[patent_doc_number] => 20060003422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Method for the identification of substances mimicking mammal epitopes'
[patent_app_type] => utility
[patent_app_number] => 11/108888
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5519
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003422.pdf
[firstpage_image] =>[orig_patent_app_number] => 11108888
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/108888 | Method for the identification of substances mimicking mammal epitopes | Apr 18, 2005 | Abandoned |
Array
(
[id] => 6945265
[patent_doc_number] => 20050197314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines'
[patent_app_type] => utility
[patent_app_number] => 11/110189
[patent_app_country] => US
[patent_app_date] => 2005-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21784
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20050197314.pdf
[firstpage_image] =>[orig_patent_app_number] => 11110189
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/110189 | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines | Apr 18, 2005 | Abandoned |
Array
(
[id] => 7247517
[patent_doc_number] => 20050272120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor'
[patent_app_type] => utility
[patent_app_number] => 11/102501
[patent_app_country] => US
[patent_app_date] => 2005-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 65981
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272120.pdf
[firstpage_image] =>[orig_patent_app_number] => 11102501
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/102501 | Compositions and methods for the diagnosis and treatment of tumor | Apr 7, 2005 | Abandoned |
Array
(
[id] => 7182910
[patent_doc_number] => 20050191313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Vaccine and immunotherapy for solid nonlymphoid tumor and related immune dysregulation'
[patent_app_type] => utility
[patent_app_number] => 11/097873
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18897
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191313.pdf
[firstpage_image] =>[orig_patent_app_number] => 11097873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/097873 | Vaccine and immunotherapy for solid nonlymphoid tumor and related immune dysregulation | Mar 31, 2005 | Abandoned |
Array
(
[id] => 5880515
[patent_doc_number] => 20060029597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'IgA antibody protein as a cytotoxic drug'
[patent_app_type] => utility
[patent_app_number] => 11/094302
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7805
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029597.pdf
[firstpage_image] =>[orig_patent_app_number] => 11094302
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/094302 | IgA antibody protein as a cytotoxic drug | Mar 30, 2005 | Abandoned |
Array
(
[id] => 5230239
[patent_doc_number] => 20070292346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk'
[patent_app_type] => utility
[patent_app_number] => 10/593799
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 41401
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20070292346.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593799
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593799 | Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk | Mar 24, 2005 | Abandoned |